TNF and rheumatoid arthritis: Endothelial progenitor cells have the ability to differentiate into endothelial cells in situ and limit the formation of atherosclerotic plaque, and short-term treatment of RA with TNF-α antagonists is associated with an increase in circulating endothelial progenitor cells [107].